Investing.com -- Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) stock surged 12% after the U.S. Food and Drug Administration (FDA) approved EMPAVELI® (pegcetacoplan) as the first treatment for C3 ...

C3.ai has the ingredients to build a sustainable enterprise AI business. There are risks that could derail C3.ai's expansion.

The all-new LG C5 OLED TV was released in March of this year, and Amazon just dropped the 55-inch model to $1,396.99 - a new ...

Unisys Corporation UIS is scheduled to release second-quarter 2025 results on July 30. The Zacks Consensus Estimate for UIS’ ...